Skip to main content
. Author manuscript; available in PMC: 2013 Jun 6.
Published in final edited form as: Liver Transpl. 2012 Apr;18(4):461–467. doi: 10.1002/lt.23376

TABLE 3. Final Multivariate Cox Proportional Hazards Models for Predicting Mortality, Death or Graft Loss Due to HCV, and Significant Fibrosis.

Predictor HR 95% CI P Value
Mortality
 HW ethnicity 1.06 0.71-1.60 0.77
 Age (per 10 years) 1.43 1.09-1.87 0.01
 Donor age
 (per 10 years)
1.25 1.10-1.87 <0.001
 Treated acute rejection 1.47 1.01-2.29 0.048
Death or Graft Loss Due to HCV
 HW ethnicity 1.04 0.53-2.05 0.91
 Female sex 2.37 1.21-4.64 0.01
 Donor age
 (per 10 years)
1.51 1.19-1.91 0.001
 CIT (per hour) 1.12 1.01-1.23 0.03
Significant Fibrosis
 HW ethnicity 2.42 1.01-5.78 0.046
 MHI (per $10,000) 1.11 1.03-1.19 0.01
 Ethnicity-MHI 0.82 0.68-0.98 0.03
 interaction
 Donor age
 (per 10 years)
1.13 1.02-1.25 0.02
 CIT (per hour) 1.06 1.01-1.11 0.03

NOTE: The variables evaluated in the univariate and multivariate models included ethnicity, age at transplantation, sex, MHI, highest level of education, insurance status, BMI, diabetes, hypertension, hyperlipidemia, MELD score, donor type, HCC, donor age, CIT, cyclosporine use, post-LT HCV treatment (as a time-varying covariate), CMV treatment, treated acute rejection, and interaction terms (between ethnicity and MHI, highest level of education, insurance status, and center). All multivariate models were controlled for the center.